UNSPSC 41131806: Blood cell diluent

In this classification a blood cell diluent is a device used to dilute blood for further testing, such as blood cell counting US FDA regulates Blood cell diluent under 21 CFR 864.8200 and under FDA product code GIF.

UNSPSC 41131806 Blood cell diluent is a Commodity code covering laboratory reagents and consumables that state and local public health agencies and clinical laboratory operations procure for blood analysis, hemoglobin testing, and related hematological diagnostics. Recent solicitations show state health departments buying both culture media and reagents for public health laboratory infrastructure, and specialized hemoglobin testing systems with associated consumables and accessories for clinical diagnostics at state laboratory facilities. The work centers on materials and equipment that meet strict technical specifications for sterility, growth characteristics, and performance compatibility with existing laboratory protocols, structured as itemized unit purchases or equipment acquisitions with firm pricing and no substitutions without advance approval.

State departments of public health and state health and human services agencies drive recent activity, with California's Department of Public Health and the Texas Health and Human Services Commission and Department of State Health Services both soliciting under the code in 2026. The California Department of Public Health posted RFB-IS-27200117-1 on August 30, 2026, due September 4, 2026, for public health laboratory supplies and media across California's infrastructure, with set-asides for certified small businesses, minority-owned enterprises, women-owned businesses, and disabled veteran-owned businesses under California procurement regulations. The Texas Health and Human Services Commission and Department of State Health Services issued IFB HHS0017310 on May 1, 2026, due May 18, 2026, for a D-10 Hemoglobin Testing System with Rack Loader at the South Texas Lab in Harlingen, with historical spending guidance of $45,050 to $80,000 for similar goods in fiscal year 2025, and evaluation on bidder qualifications, performance capability, and price rather than low-bid award alone.